Introduction

40
Staphylococcus aureus (SA) is a widespread commensal bacterium that, because of its 41 pathogenicity and ability to persist in hospital settings, has become a global healthcare concern.
42
This gram positive coccus colonizes the anterior nares of roughly 30% of the population, and 43 several of its characteristics allow it to become virulent and disseminate effectively through the 44 host (1). Epidemiological reports estimate that there are annually 477,927 hospitalizations and 45 29,164 deaths that were related to SA in the United States alone (2). In addition to antibiotic 46 resistance, the ability to form a community of cells, or biofilm, is a virulence factor that can 47 promote transmission and exacerbate disease.
48
Bacterial biofilms are ubiquitous and likely the predominant form in which most 49 prokaryotes exist in nature (3). As bacterial cells grow collectively, they are able to create a 50 protective extracellular matrix and initiate other processes that ultimately increase their viability.
51
Potential benefits include amplified resistance to bactericidal agents such as antibiotics, Molecules) that allow cells to adhere to a wide variety of surfaces (6). Once adhered, a distinct 56 set of genes become activated, resulting in the formation of a biofilm (7). Exopolysaccharides, 57 proteins, extracellular DNA (eDNA), and other polymers have been identified as some of the 58 important constituents of the extracellular matrix that promote intercellular adhesion (8, 9) .
59
Although there is a spectrum of biofilm types in SA, in general they are often characterized as 60 being either polysaccharide-based or eDNA and protein-based (10).
61
The capacity to form robust biofilms is clinically relevant. Although there are countless 62 SA isolates that have arisen from the community and entered hospitals, there are currently only 63 five major clonal lineages of S. aureus that account for the majority of nosocomial infections at a 64 global level (11) . When one such strain arose in Brazil during the 1990s, it was discovered that it 65 had a much greater ability to produce biofilms and to adhere to polystyrene surfaces (in addition 66 to being multi-drug resistant, a property shared by other strains) (6, 12 DNase. We also noted that the 2 MRSA isolates that were not significantly affected by either 183 treatment alone were susceptible to a combinatorial treatment.
184
We then analyzed our data by strain type (MRSA, MSSA, or total SA) to determine if 185 there were differences in susceptibility of the two many types of isolates to the three different 186 treatments mentioned above (Fig. 4) weight. Other types of metal nanoparticles, or nanoparticles of varying sizes, could also be 261 explored for anti-SA biofilm activity.
262
Materials and Methods
264
Isolation and sources of SA
265
Nine SA strains were used in this study. Strains M1, M6 and M7 were isolated from a 266 sports training facility in Utah. Strain HA1 is a local hospital-associated isolate. Strain USA300-
267
GA92 was acquired from BEI resources (Manassas, VA,), and strains SA29213, SA12600, DNA was extracted from SA strains (41), and the icaD gene was detected via PCR.
281
Primers used were F: (5' -GAACCGCTTGCCATGTGTTG -3') and R: (5' -282 GCTTGACCATGTTGCGTAACC -3') giving a product of 483 bp as described by (42), and 283 confirmed with the control strain USA300 0114. Thermal cycling parameters were followed as 284 described by each source with the exception that we performed 40 cycles of the amplification 
